Williams honored for Outstanding Achievement by ASGCT
January 23, 2012
Congratulations to David Williams, MD, chief of the Division of Hematology/Oncology and director of Translational Research at Children's, and associate chair of Pediatric Oncology at Dana-Farber Cancer Institute, who has been selected by the American Society of Gene & Cell Therapy as the recipient of their 2012 Outstanding Achievement Award.
The ASGCT's highest honor, the Outstanding Achievement Award recognizes one Society member per year, who has achieved pioneering research success, specific high impact accomplishments, or a lifetime of significant contributions to the field of gene and cell therapy. Williams was nominated by his peers for his exceptional body of work, ranging from his initial development of retrovirus vectors in gene transfer to hematopoietic stem cells, and the study of the interaction of hematopoietic stem cells with bone marrow, to his service to the Society, editing and elevating the Molecular Therapy journal to its current standing, and for organization of international cooperatives in the field. Williams is only the fifth researcher to receive this award.
Williams will be presented with the award at the ASGCT's 15th Annual Meeting in Philadelphia, PA, on May 17, where he will also present a talk covering the highlights of his outstanding career in gene and cell therapy.